DuPont: Barclays initiates coverage with overweight rating; target price $156
DD•Barclays initiated coverage of DuPont with an overweight rating and a $156 target price.
Related News
Natera, TransCode Therapeutics partner on Phase 2a colorectal cancer trial enrollment using Signatera MRD test
RNAZ•
FTI Consulting names Adel Turki president of Compass Lexecon North America
FCN•
JPMorgan rises, Wells Fargo falls after Q3 results
WFC•
Equifax: Clear Street cuts target price to $160 from $190
EFX•
SJF Bank says Denmark inflation rises to 2.2% in September, still far below 2022 peak
SPY•